Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

84.24
-1.5400-1.80%
Post-market: 84.240.00000.00%19:30 EDT
Volume:6.52M
Turnover:545.37M
Market Cap:48.57B
PE:49.00
High:85.78
Open:85.65
Low:82.43
Close:85.78
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:2.08
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.57
PE(LYR):45.96

Loading ...

Tulyp Medical names Steve Motes CEO; Sofinnova’s Mano Iyer shifts to board

Reuters
·
May 18

Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 14

Edwards CEO Bernard Zovighian disposes of EW shares worth $2.09 million

Reuters
·
May 13

Edwards CVP JAPAC Wayne Markowitz disposes 1,083 shares for $86,531.35

Reuters
·
May 12

Edwards Lifesciences Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
May 12

EW Scripps Is Maintained at Buy by Benchmark

Dow Jones
·
May 12

Sensor Tower: "Honor of Kings" Surges to Top Global Mobile Game Revenue Chart

Stock News
·
May 11

Edwards Lifesciences Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
May 09

Edwards Lifesciences Shareholders Approve Expanded Equity Incentive Plan

TIPRANKS
·
May 09

Edwards Lifesciences shareholders approve 7 million-share increase to stock incentive plan limit

Reuters
·
May 09

Top Edwards Lifesciences Executive Makes Notable Insider Move

TIPRANKS
·
May 05

Edwards Lifesciences CVP Daniel J. Lippis disposes of $85,397.66 in shares

Reuters
·
May 05

BRIEF-Edwards Lifesciences Announces Appointment Of CFO

Reuters
·
May 05

Edwards Lifesciences names Doretta Mistras CFO, succeeding Scott Ullem

Reuters
·
May 05

Edwards Lifesciences appoints Theodora Mistras as CFO

TIPRANKS
·
May 05

Edwards Lifesciences Announces Appointment of CFO

THOMSON REUTERS
·
May 05

Edwards Lifesciences Corp - Appoints Theodora (Doretta) Mistras as CFO Effective End of May

THOMSON REUTERS
·
May 05

Edwards Lifesciences Maintained at Buy as Strong Q1 Results and RESILIA Durability Data Support Elevated 2026 Outlook and Unchanged $97 Price Target

TIPRANKS
·
May 04

Edwards Lifesciences announces 10-year results from Commence aortic trial

TIPRANKS
·
May 04

Edwards says COMMENCE trial shows 97.9% freedom from valve deterioration at 10 years

Reuters
·
May 02